Nearly a third of medical device adverse events were not submitted to the FDA within a 30-day regulatory window, with most ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Lilly has taken a non-exclusive license to deploy Dexcom’s CGM systems – which include app-based remote monitoring and alarm functions – in pen- and pump-based insulin systems that form the ...
Medical Device Network on MSN5d
Analysts say Dexcom’s FDA warning unlikely to impact 2025 revenueDexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...
Both groups used a Dexcom G6 Continuous Glucose Monitoring (CGM ... The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ ...
Insulet reported a higher-than-expected profit in the fourth quarter on Thursday, driven by strong demand for its wearable insulin pumps.
"It is a natural evolution of our mission to bring the same AID technology that helped to make Tandem the #1 recommended insulin pump brand by ... Both groups used a Dexcom G6 Continuous Glucose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback